Rise in the prevalence of cardiovascular diseases, and growing demand for implantable devices are expected to augment the market at a healthy CAGR of 7.80% during the forecast period of 2022 to 2030

Market Research Future (MRFR) has published a cooked research report on the “Global Biomaterials Market” that contains the information from 2022 to 2030. The biomaterials market is expected to register a CAGR of 7.80% during the forecast period 2022-2030, to reach USD 212,405.2 million by 2030.

MRFR recognizes the following companies as the key players in the global biomaterials market— Royal DSM (Netherlands), BASF SE (Germany), Corbion N.V. (Netherlands), Covestro (Germany), Invibio Ltd. (UK), Carpenter Technology Corporation (US), Evonik Industries AG (Germany), Berkeley Advanced Biomaterials, Inc. (US), CAM Bioceramics BV (Netherlands), Celanese Corporation (US), Wright Medical Technology, Inc. (US), Zimmer Biomet Holdings, Inc. (US), Bayer AG (Germany), Collagen Matrix (US).

Market Highlights

The Biomaterial Market is expected to reach USD 212.40 billion by 2030 at 7.80% CAGR during the forecast period 2022-2030

Biomaterials gained tremendous attention in regenerative medicine and tissue engineering applications attributed to their ability to enhance functional tissue regeneration. The biomaterials market has been segmented into type and application. The market is driven by factors like the rising prevalence of cardiovascular diseases and the growing demand for implantable devices increasing wound healing therapies. However, the high price of implantable biomaterials could hamper the market growth of the biomaterials.

Segment Analysis

The global biomaterials market is segmented into type, application, and region. The type segment is further segmented into metallic, ceramics, polymeric, and natural biomaterials. The application is segmented into joint replacements, ophthalmology, cardiovascular, wound healing, plastic surgery, neurological conditions, and others.

Regional Analysis

The global biomaterials market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World.

The North America held the largest market share in 2021 due the factors such as developed healthcare infrastructure and key players in the region driving growth through new product launches, expansion, and acquisitions. In addition, cosmetic surgery is extremely popular in North America. According to the article published in the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), 1.4 million surgical and non-surgical treatments with plastic surgeons performing around 600 procedures have been done in 2020, a 40% increase. Moreover, Miami is also considered the plastic surgery capital of the US due to the city's high concentration of plastic surgeons. Hence, an increase in the number of plastic surgeries is driving the demand for biomaterials in the North American region.

The Europe biomaterials market is growing at a higher rate, which is expected to continue in the coming years. The market growth rate is directly influenced by the advancements made in the diagnosis and treatment of injuries and diseases in part by the invention of biomaterials, which help to ease pain, save lives, and along with that assist in preserving the quality of life. Additionally, a new generation of inexpensive materials called tissue-engineered materials is being made to help repair natural tissue. Besides, ongoing developments in the design of medical software will facilitate surgeons to operate precise models to help in their preparation for more intricate surgeries.

The Asia-Pacific region is attributed to show the highest CAGR during the forecast period. This is due to the factors like rising cosmetic and plastic surgeries, growing elderly population in this area leads to an increase in bone fractures and surgical demand, propelling market expansion.  India and China are two key countries that contribute significantly to the Asia Pacific's market share. Furthermore, the rising patient population, implanted device acceptance, CVD awareness, and improved healthcare infrastructure drive the market of biomaterials in this area to develop.

The increase in government funding and the availability of new technologies such as hydrogen scaffolding and decellularized dermal matrixes for grafting are some of the factors driving the growth of the rest of the world biomaterials market. Furthermore, due to the increasing number demand for the usage of biomaterials in cardiology wound healing, neurology, and plastic surgery is also on the rise. Besides, it will help to contribute to the market growing at a healthy rate throughout the forecast period.

Key Findings of the Study

• The global biomaterials market is estimated to reach USD 2,12,405.2 million by 2030 at a CAGR of 7.80 % during the assessment period.


• North America accounted for the largest share of the global market of biomaterials due to the increasing demand for implantable devices and the presence of key players in the region.


• Based on type, the metallic segment accounted for the largest market in 2021.


• By application, the orthopedic segment accounted for the largest market in 2021.

Some of the key players operating in the biomaterials market are Royal DSM (Netherlands), BASF SE (Germany), Corbion N.V. (Netherlands), Covestro (Germany), Invibio Ltd. (UK), Carpenter Technology Corporation (US), Evonik Industries AG (Germany), Berkeley Advanced Biomaterials, Inc. (US), CAM Bioceramics BV (Netherlands), Celanese Corporation (US), Wright Medical Technology, Inc. (US), Zimmer Biomet Holdings, Inc. (US), Bayer AG (Germany), Collagen Matrix (US).

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Biomaterial Market Research Report